Featured Story | By Nick Paul Taylor Regeneron has ended a collaboration with Ocular Therapeutix to develop a sustained-release version of Eylea. The termination follows the failure of the first formulation to meet the goals of the program and the submission of other candidates to Regeneron for preclinical assessment. read more |
| |
|---|
|
|  | Webinar: Avoiding pitfalls in sterile manufacturing Thursday, September 9, 2021 | 11am ET / 8am PT The rapid development of COVID-19 vaccines brought to light the challenges involved in ramping up the production of injectables. Companies struggled to compress a year-long process of getting up to speed into a matter of months. Such pitfalls can be avoided by improving planning processes and adopting new technologies to streamline manufacturing. Register Now. |
Top Stories By Nick Paul Taylor Oyster Point Pharma has sold the rights to two nasal sprays for patients with dry eye disease in greater China to Ji Xing Pharmaceuticals for $17.5 million upfront. The deal comes ahead of an FDA decision that could make one of the drugs the first nasal spray approved for dry eye disease. read more By Nick Paul Taylor Eyevensys has raised $12 million to fund development of gene therapies based on its ocular delivery platform. The biotech is using an electrical pulse generator and an ocular device to get plasmids to targets in the eye without using the viral vectors typically needed to administer gene therapies. read more By Nick Paul Taylor Inflammasome Therapeutics has received funding to develop a sustained-release formulation that provides protection from HIV infection and birth control for 12 months. The Bill & Melinda Gates Foundation is bankrolling the project through a $1.3 million grant. read more By Ben Adams Philip Morris first starting selling tobacco products to the public all the way back in 1847, but, more than 170 years later, the company has read the tea leaves and the future is “smoke-free.” read more By Angus Liu As Novartis' gene therapy Zolgensma makes inroads in newborns diagnosed with spinal muscular atrophy, the company is looking to expand the drug’s reach to older patients with a new formulation. After a safety scare and a regulatory setback, the Swiss pharma is now back on track with that plan. read more Resources Sponsored by: Patheon by Thermo Fisher Scientific Learn how a decentralized clinical trial strategy improves patient recruitment, reduces drop-out rates, and ultimately streamlines the path to the next trial phase. Sponsored by: Patheon by Thermo Fisher Scientific Learn how to build a robust packaging strategy and the key technical considerations in packaging design and operational planning to enable rapid commercialization of pharmaceuticals. Sponsored by: Patheon by Thermo Fisher Scientific Learn how regulations are changing and key considerations for commercializing cell and gene therapies without sacrificing quality. Sponsored by: LabVantage Solutions Uncover the real impact of “digital transformation” with practical advice to help you plan your own transformative journey to a harmonized digital ecosystem. Sponsored by: Box Read Get to Know Cloud Content Management for Life Sciences and learn how to eliminate silos across all workflows, from R&D to commercialization. Sponsored by: Cytiva A one-stop hub for Cytiva resources to support process intesification Sponsored by: Cytiva A one-stop hub for Cytiva resources to support process development and manufacturing of your novel molecule Sponsored By: Remarque Systems Remarque Systems consolidates data, then layers on visualization and automated metrics to generate consistent, actionable data insights in real-time. Click here for more info. Sponsored By: Within3 We enable virtual work — offering over-time sessions where participants are more focused, insights are more diverse and business goals are met. Sponsored by: Catalent Discover the current state of patient-focused dose design through clinical evidence, real-world case studies and patient preference-driven drug design solutions that can help develop better treatments and successful real-world outcomes. Sponsored by: Catalent This eBook features insights from experts in the industry on patient-centric drug development challenges and strategies on advancing drug design and development effectively. Sponsored by: Catalent Learn about drug product process development challenges and risks, the difference between innovator and biosimilar drug product process development, and more during the drug product process development phase. | 
